Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure
NCT00293150
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class
Stopped
Lack of eligible patients
Conditions
Diastolic Heart Failure
Interventions
DRUG:
Eplerenone
Sponsor
The Cleveland Clinic